Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Oct 04,2018
Cholesterol-Related Gene Variants Impart Benefits, Point to New Drugs
From the DNA of nearly 300,000 veterans, scientists have singled out a handful of genetic mutations that not only govern levels of cholesterol, but may also inform the development and use of drugs for cardiovascular disease and diabetes, or abdominal aortic aneurysms.   The study scientists, led by a group at Stanford University School ofRead more
More
Oct 04,2018
Algorithm Could Help Scientists Split a Protein and Reassemble It to Functionality
According to a team of biochemists and biophysicists it's almost impossible for proteins to be split up and reassembled on command, however the researchers claim that a computer model could be another step towards using chemical and light signals to create new medical treatments and biosensors. The team published its study ("Computational design of chemogeneticRead more
More
Oct 03,2018
Protein Regulator of Glioblastoma Migration Identified
A specific protein called TEAD1 is an important regulator of tumor migration in glioblastoma, the most common brain tumor in adults, and deactivating this protein may stop tumor cells from migrating away from the main tumor mass, according to research conducted at the Icahn School of Medicine at Mount Sinai.  The data garnered through thisRead more
More
Protein Regulator of Glioblastoma Migration Identified
Oct 03,2018
Major Advance Reported in Understanding Antibiotic Resistance
Scientists at the University of Montana (UM) and the University of Washington have discovered how pathogenic bacteria resist antibiotic treatment and recently published their findings in an article titled ("Entropically-driven aggregation of bacteria by host polymers promotes antibiotic tolerance in Pseudomonas aeruginosa”) in the Proceedings of the Natural Academy of Sciences. "Bacteria causing chronic infections are generally observedRead more
More
Oct 02,2018
Immunotherapy Pioneers Take 2018 Nobel Prize
This year 2018, the Nobel committee has sought to recognize the enormous potential and meteoric rise in success of immunotherapy as a strategy for treating cancer. By stimulating the inherent ability of our immune system to attack tumor cells this year's Nobel Laureates have established an entirely new principle for cancer therapy.   Specifically, theRead more
More
Oct 02,2018
Brain Defects Linked to Growth Factor Hormone
Investigators at the Medical University of South Carolina (MUSC) made a recent discovery that could provide crucial insights into structural changes within the brain and have a profound impact on dietary habits to improve overall brain health. The new study showed that high levels of fibroblast growth factor 23 (FGF23) were associated with structural changesRead more
More
Brain Defects Linked to Growth Factor Hormone
Oct 01,2018
Novel Alzheimer's Mechanism May Have Uncovered New Treatment Strategy
The specific cause of Alzheimer's disease (AD) remains unclear and has even caused a Shakespearean-like feud among scientists with the amyloid family on one side not wanting to fraternize with the tau folks! Ok, perhaps that's bit overdramatic, but researchers often ascribe to one AD theory over the other. However now, investigators at Rutgers UniversityRead more
More
Novel Alzheimer's Mechanism May Have Uncovered New Treatment Strategy
Oct 01,2018
DNA Vaccine Shows Promise for Cancer Immunotherapy
Scientists at The Wistar Institute have implemented a novel structurally designed synthetic DNA vaccine to simultaneously target multiple members of a family of proteins that are specifically overexpressed in several types of cancer. They say their approach addressed a difficult issue in cancer immunotherapy, specifically how to simultaneously drive antitumor immune responses against multiple tumorRead more
More
DNA Vaccine Shows Promise for Cancer Immunotherapy
Sep 30,2018
Scientists establish a new method of ion channel drug research
On September 26, the journal Nature Communications published an online publication of the Cai Shiqing Research Group of the Institute of Neuroscience of the Chinese Academy of Sciences, the Center for Excellence in Brain Science and Intelligent Technology of the Chinese Academy of Sciences, the State Key Laboratory of Neuroscience and the Beijing Anzhen HospitalRead more
More
Scientists establish a new method of ion channel drug research
Sep 28,2018
Stem Cell Discovery Could Lead to Blood Vessel Repair
Life-changing treatments for cardiovascular disease are on the horizon after scientists made a groundbreaking discovery that could enable them to grow new blodd vessels.   University College London (UCL) scientists report that a unique source of stem cells in blood helps to build blood vessels in the growing embryo. They say their study ("Erythro-myeloid progenitors contributeRead more
More
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->